Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution.
Saved in:
| Title: | Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution. |
|---|---|
| Authors: | Edelstein GE; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sass TN; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Deo R; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Glover OT; Ragon Institute of Mass General Brigham, Cambridge, Massachusetts, USA., Boucau J; Ragon Institute of Mass General Brigham, Cambridge, Massachusetts, USA., Jaganathan P; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Chew KW; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA., Giganti MJ; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Hughes MD; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Moser C; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Javan AC; National Institutes of Health, Bethesda, Maryland, USA., Fletcher CV; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA., McCarthy C; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Currier JS; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA., Singh U; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Smith DM; Department of Medicine, University of Carolina, San Diego, La Jolla, California, USA., Fischer W; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Barczak AK; Ragon Institute of Mass General Brigham, Cambridge, Massachusetts, USA., Choudhary MC; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Li JZ; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| Corporate Authors: | ACTIV-2/A5401 Study Team |
| Source: | Microbiology spectrum [Microbiol Spectr] 2026 Jul 07; Vol. 14 (7), pp. e0054126. Date of Electronic Publication: 2026 May 18. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
